标题
Thiazolidinediones and fracture risk in patients with Type 2 diabetes
作者
关键词
-
出版物
DIABETIC MEDICINE
Volume 28, Issue 7, Pages 759-771
出版商
Wiley
发表日期
2010-11-09
DOI
10.1111/j.1464-5491.2010.03187.x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- PGC1β Mediates PPARγ Activation of Osteoclastogenesis and Rosiglitazone-Induced Bone Loss
- (2010) Wei Wei et al. Cell Metabolism
- Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
- (2010) R. E. Aubert et al. DIABETES OBESITY & METABOLISM
- Thiazolidinediones and Fractures: Evidence from Translating Research into Action for Diabetes
- (2010) Dori Bilik et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus
- (2010) Zeina A. Habib et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Management of glucocorticoid-induced osteoporosis
- (2010) Juliet Compston Nature Reviews Rheumatology
- Thiazolidinediones and Fractures in Men and Women
- (2009) Colin R. Dormuth et al. ARCHIVES OF INTERNAL MEDICINE
- Vertebral fractures in males with type 2 diabetes treated with rosiglitazone
- (2009) Tatiana Mancini et al. BONE
- Thiazolidinedione use and the risk of fractures
- (2009) K. A. Toulis et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis
- (2009) B. Gustafson et al. DIABETOLOGIA
- The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case–control study
- (2009) F.-Y. Hsiao et al. DIABETOLOGIA
- Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes
- (2009) John Dormandy et al. DRUG SAFETY
- Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss
- (2009) Laura E. Targownik et al. GASTROENTEROLOGY
- Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression
- (2009) Lana J. Williams et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factors
- (2009) G. Schernthaner INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- The effect of thiazolidinediones on bone mineral density in Chinese older patients with type 2 diabetes
- (2009) Hong Li et al. JOURNAL OF BONE AND MINERAL METABOLISM
- A Cohort Study of Thiazolidinediones and Fractures in Older Adults with Diabetes
- (2009) Daniel H. Solomon et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
- (2009) Bernard Zinman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Pioglitazone and mechanisms of CV protection
- (2009) E. Erdmann et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
- (2009) Unni Syversen et al. BMC Endocrine Disorders
- The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study
- (2009) Ian J. Douglas et al. PLOS MEDICINE
- Use of Thiazolidinediones and Fracture Risk
- (2008) Christian Meier et al. ARCHIVES OF INTERNAL MEDICINE
- Selective Serotonin Reuptake Inhibitors and Other Antidepressants and Risk of Fracture
- (2008) Peter Vestergaard et al. CALCIFIED TISSUE INTERNATIONAL
- Use of proton pump inhibitors and risk of osteoporosis-related fractures
- (2008) L. E. Targownik et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
- (2008) Y. K. Loke et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Osteoporosis among patients with type 1 and type 2 diabetes
- (2008) A. Räkel et al. DIABETES & METABOLISM
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Exposure to antiepileptic drugs and the risk of hip fracture: A case-control study
- (2008) Ioannis Tsiropoulos et al. EPILEPSIA
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fracture Risk in Type 2 Diabetes: Update of a Population-Based Study
- (2008) L Joseph Melton et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Association of Pioglitazone Treatment with Decreased Bone Mineral Density in Obese Premenopausal Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial
- (2008) Dorte Glintborg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy
- (2008) A. M. Pack et al. NEUROLOGY
- Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors
- (2008) James A Kaye et al. PHARMACOTHERAPY
- Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy
- (2008) Merete Alice Lyngstad‐Brechan et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now